Mr. Huang Guo, Deputy Commissioner of China NMPA Visits Chime Biologics Wuhan Headquarter
April 9, 2024, Wuhan, China – Chime Biologics, a leading global CDMO that enables its partners’ success in biologics, today is visited by Mr. Huang Guo, Deputy Commissioner of China NMPA with his delegation. Leaders from Hubei Medical Products Administration and Wuhan East Lake High-tech Development Zone also jointed the visit, accompanied by Mr. Jimmy Wei, President of Chime Biologics.
Under the guidance of Mr. Jimmy Wei, President of Chime Biologics, Mr. Huang Guo and his delegation went into KUBio, the first modular biopharmaceutical plant in the world, for a site visit. Mr. Huang Guo spoke highly of Chime Biologics’ expertise in the field of biopharmaceutical manufacturing to meets international quality standards. He encouraged Chime Biologics to pioneer technological innovation and improve service capability and product quality.
Mr. Huang Guo and his delegation visited KUBio, the first modular biopharmaceutical plant in the world.
Mr. Jimmy Wei, President of Chime Biologics, noted, “Biopharmaceutical CDMO has a broad development prospect. Chime Biologics will continue to expand its investment in Hubei, bring more biopharmaceutical products from all over the country and the world to Wuhan for R&D and production, and help Wuhan build a high-quality global new drug center. Chime Biologics will continue to strengthen the communication and cooperation with NMPA, deep dive in the industry to promote the innovation and development of the biopharmaceutical industry.”
About Chime Biologics
Chime Biologics is a leading CDMO that has introduced the first modular biopharmaceutical plant KUBio in the world to empower its partners’ success in biologics in the whole process from cell line development to commercial manufacturing. Relying on cell line development and advanced technology development from our Shanghai Innovation Center and proven success in IND-enabling through BLA filing at its Wuhan plant, Chime Biologics is providing a one-stop CMC solution for biopharmaceutical customers around the world. We share a common goal to make cutting-edge biomedicines affordable and accessible to all patients globally, fulfilling its commitment to human health. For more information, please visit: www.chimebiologics.com
